A phase II study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in patients with HER2-positive metastatic solid tumors and metastases to brain (TUCATEMEB)

被引：0
|
作者：
Dumbrava, Ecaterina E.
Kennon, Amber M.
Murthy, Rashmi K.
Montazari, Emma J.
Tawbi, Hussein
Li, Jing
Lang, Frederick F.
Sanchez, Gisela
Wang, Jianbo
Glitza, Isabella C.
O'Brien, Barbara J.
Beckham, Thomas
Swanson, Todd
Tom, Martin C.
Vu, Uyen M.
Darko, Tanisha T.
Cai, Tiantian
Shah, Komal
Meric-Bernstam, Funda
Rodon, Jordi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT289
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT289
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer
    Spring, Laura M.
    Clark, Shealagh L.
    Li, Tianyu
    Goel, Shom
    Tayob, Nabihah
    Viscosi, Elene
    Abraham, Elizabeth
    Juric, Dejan
    Isakoff, Steven J.
    Mayer, Erica
    Moy, Beverly
    Supko, Jeffrey G.
    Tolaney, Sara M.
    Bardia, Aditya
    NPJ BREAST CANCER, 2021, 7 (01)
  • [32] Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series
    O'Sullivan, Ciara C.
    Higgins, Alexandra S.
    Alkurashi, Adham K.
    Ahluwalia, Vaibhav
    Taraba, Jodi L.
    Mckie, Paul M.
    Kamath, Patrick S.
    Iyer, Vivek N.
    Haddad, Tufia C.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer
    Laura M. Spring
    Shealagh L. Clark
    Tianyu Li
    Shom Goel
    Nabihah Tayob
    Elene Viscosi
    Elizabeth Abraham
    Dejan Juric
    Steven J. Isakoff
    Erica Mayer
    Beverly Moy
    Jeffrey G. Supko
    Sara M. Tolaney
    Aditya Bardia
    npj Breast Cancer, 7
  • [34] Ado-trastuzumab emtansine (T-DM1) in HER2+advanced breast cancer patients: does pretreatment with pertuzumab matter?
    Fabi, Alessandra
    Giannarelli, Diana
    Moscetti, Luca
    Santini, Daniele
    Zambelli, Alberto
    De laurentiis, Michelino
    Caruso, Michele
    Generali, Daniele
    Valle, Enrichetta
    Leonardi, Vita
    Cannita, Katia
    Arpino, Grazia
    Filippelli, Gianfranco
    Ferretti, Gianluigi
    Giampaglia, Marianna
    Montemurro, Filippo
    Nistico, Cecilia
    Gasparro, Simona
    Cognetti, Francesco
    FUTURE ONCOLOGY, 2017, 13 (30) : 2791 - 2797
  • [35] Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients
    Kowalczyk, Lidia
    Bartsch, Rupert
    Singer, Christian F.
    Farr, Alex
    BREAST CARE, 2017, 12 (06) : 401 - 408
  • [36] Brain metastases and ado-trastuzumab emtansine (TDM-1) treatment in HER2 positive metastatic patients: an Italian multicenter analysis
    Fabi, A.
    Alesini, D.
    Valle, E.
    Carbognin, L.
    Arpino, G.
    Santini, D.
    Montemurro, F.
    Ciccarese, M.
    Cannita, K.
    Paris, I.
    Moscetti, L.
    De laurentiis, M.
    Zambelli, A.
    La Verde, N.
    Nistico, C.
    Ferretti, G.
    Gasparro, S.
    Giannarelli, D.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
    Ian E. Krop
    Shanu Modi
    Patricia M. LoRusso
    Mark Pegram
    Ellie Guardino
    Betsy Althaus
    Dan Lu
    Alexander Strasak
    Anthony Elias
    Breast Cancer Research, 18
  • [38] Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
    Krop, Ian E.
    Modi, Shanu
    LoRusso, Patricia M.
    Pegram, Mark
    Guardino, Ellie
    Althaus, Betsy
    Lu, Dan
    Strasak, Alexander
    Elias, Anthony
    BREAST CANCER RESEARCH, 2016, 18
  • [39] Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study
    Kojima, Yasuyuki
    Yoshie, Reiko
    Kawamoto, Hisanori
    Shimo, Arata
    Uejima, Tomoko
    Iwatani, Tsuguo
    Motoyoshi, Ai
    Kanemaki, Yoshihide
    Boku, Narikazu
    Tsugawa, Koichiro
    ONCOLOGY, 2019, 96 (06) : 309 - 317
  • [40] Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
    Lu, Dan
    Burris, Howard A., III
    Wang, Bei
    Dees, E. Claire
    Cortes, Javier
    Joshi, Amita
    Gupta, Manish
    Yi, Joo-Hee
    Chu, Yu-Waye
    Shih, Ted
    Fang, Liang
    Girish, Sandhya
    CURRENT DRUG METABOLISM, 2012, 13 (07) : 911 - 922
12345